Cheng, H., Ballman, K., Vassilakopoulou, M., Dueck, A. C., Reinholz, M. M., Tenner, K., . . . Perez, E. A. (2014). EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial. Br J Cancer.
Style de citation ChicagoCheng, H., et al. "EGFR Expression Is Associated With Decreased Benefit From Trastuzumab in the NCCTG N9831 (Alliance) Trial." Br J Cancer 2014.
Style de citation MLACheng, H., et al. "EGFR Expression Is Associated With Decreased Benefit From Trastuzumab in the NCCTG N9831 (Alliance) Trial." Br J Cancer 2014.
Attention : ces citations peuvent ne pas être correctes à 100%.